[go: up one dir, main page]

DK0637236T3 - Pharmaceutical composition and process for its preparation - Google Patents

Pharmaceutical composition and process for its preparation

Info

Publication number
DK0637236T3
DK0637236T3 DK93908973.6T DK93908973T DK0637236T3 DK 0637236 T3 DK0637236 T3 DK 0637236T3 DK 93908973 T DK93908973 T DK 93908973T DK 0637236 T3 DK0637236 T3 DK 0637236T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical composition
prepn
clodronate
dissolves
Prior art date
Application number
DK93908973.6T
Other languages
Danish (da)
Inventor
Juhani Posti
Kirsi Katila
Pertti Rantala
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of DK0637236T3 publication Critical patent/DK0637236T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A pharmaceutical prepn. for oral use comprises, as active agent, dichloromethylene bisphosphonic acid (clodronate) (I) or a pharmacologically acceptable salt, the prepn. being enteric coated with a film which dissolves at pH 5-7.2.
DK93908973.6T 1992-04-24 1993-04-21 Pharmaceutical composition and process for its preparation DK0637236T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (en) 1992-04-24 1992-04-24 Pharmaceutical preparation and process for its preparation

Publications (1)

Publication Number Publication Date
DK0637236T3 true DK0637236T3 (en) 1997-03-17

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93908973.6T DK0637236T3 (en) 1992-04-24 1993-04-21 Pharmaceutical composition and process for its preparation

Country Status (21)

Country Link
US (1) US5525354A (en)
EP (1) EP0637236B1 (en)
JP (1) JP3536106B2 (en)
AT (1) ATE143802T1 (en)
AU (1) AU671830B2 (en)
CA (1) CA2134196C (en)
CZ (1) CZ282871B6 (en)
DE (2) DE637236T1 (en)
DK (1) DK0637236T3 (en)
EE (1) EE03107B1 (en)
ES (1) ES2094539T3 (en)
FI (1) FI110667B (en)
GR (1) GR3022249T3 (en)
HK (1) HK13097A (en)
HU (1) HU219342B (en)
IL (1) IL105403A (en)
NO (1) NO306654B1 (en)
RU (1) RU2116074C1 (en)
SE (1) SE501389C2 (en)
TW (1) TW273515B (en)
WO (1) WO1993021907A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
CA2162470C (en) * 1993-05-15 1998-06-16 Walter Preis Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (en) * 1993-11-12 1995-11-27 Leiras Oy Method for preparing a clodronate preparation
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
FI98343C (en) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Oral formulation
DE19719680A1 (en) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Use of diphosphonic acids for the preventive treatment of long-term consequences of bladder enlargement or replacement
JPH11137208A (en) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd Solid material rapidly soluble in oral cavity and its production
EP0998933A1 (en) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Process for producing pharmaceutical compositions containing diphosphonates for oral administration
EP0998932A1 (en) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Solid pharmaceutical dosage form containing diphosphonates or their salts and method for its production
JP2002537321A (en) * 1999-02-22 2002-11-05 エラン コーポレイション ピーエルスィー Solid oral dosage form containing enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
SE9901272D0 (en) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
PE20011061A1 (en) 2000-02-01 2001-11-20 Procter & Gamble SELECTIVE CRYSTALLIZATION OF 3-PYRIDYL-1-HYDROXY-ETHYLIDEN-1,1-BISPHOSPHONIC SODIUM ACID AS HEMIPENTAHYDRATE OR MONOHYDRATE
KR20030083725A (en) * 2001-03-01 2003-10-30 에미스페어 테크놀로지스, 인코포레이티드 Compositions for delivering bisphosphonates
EP1390383B1 (en) 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
BRPI0710503A2 (en) 2006-04-07 2011-08-16 Merrion Res Iii Ltd use of a pharmaceutical composition, pharmaceutical composition, and oral dosage form
JP5671451B2 (en) 2008-05-07 2015-02-18 メリオン・リサーチ・Ｉｉｉ・リミテッド Compositions and preparation processes for GnRH related compounds
DE102008022520A1 (en) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Solid sustained-release pharmaceutical formulation
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
JP2014501784A (en) 2011-01-07 2014-01-23 メリオン・リサーチ・Ｉｉｉ・リミテッド Pharmaceutical composition of iron for oral administration
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
ATE60711T1 (en) * 1986-12-20 1991-02-15 Boehringer Mannheim Gmbh PHARMACEUTICALS CONTAINING CLODRONATE AND METHOD OF MANUFACTURE THE SAME.
EP0313845A1 (en) * 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
FR2629716B1 (en) * 1988-04-07 1991-07-19 Sanofi Sa PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION BASED ON A DIPHOSPHONIC ACID DERIVATIVE

Also Published As

Publication number Publication date
CZ282871B6 (en) 1997-11-12
WO1993021907A1 (en) 1993-11-11
FI944961L (en) 1994-10-21
IL105403A (en) 1998-03-10
DE69305335T2 (en) 1997-04-30
FI110667B (en) 2003-03-14
NO944001D0 (en) 1994-10-21
DE69305335D1 (en) 1996-11-14
EP0637236B1 (en) 1996-10-09
CA2134196A1 (en) 1993-11-11
JPH07505898A (en) 1995-06-29
HU9403067D0 (en) 1994-12-28
AU3955093A (en) 1993-11-29
ES2094539T3 (en) 1997-01-16
CA2134196C (en) 2004-02-10
FI944961A0 (en) 1994-10-21
TW273515B (en) 1996-04-01
CZ261494A3 (en) 1995-02-15
AU671830B2 (en) 1996-09-12
HK13097A (en) 1997-02-14
RU94045950A (en) 1996-11-10
NO944001L (en) 1994-10-21
SE9201299D0 (en) 1992-04-24
GR3022249T3 (en) 1997-04-30
EE03107B1 (en) 1998-08-17
HUT74572A (en) 1997-01-28
JP3536106B2 (en) 2004-06-07
IL105403A0 (en) 1993-08-18
NO306654B1 (en) 1999-12-06
SE9201299L (en) 1993-10-25
SE501389C2 (en) 1995-01-30
RU2116074C1 (en) 1998-07-27
ATE143802T1 (en) 1996-10-15
EP0637236A1 (en) 1995-02-08
DE637236T1 (en) 1995-07-06
US5525354A (en) 1996-06-11
HU219342B (en) 2001-03-28

Similar Documents

Publication Publication Date Title
DK0637236T3 (en) Pharmaceutical composition and process for its preparation
SE9202250D0 (en) CONTROLLED RELEASE MORPHINE PREPARATION
ATE151285T1 (en) ORAL MEDICINAL PRODUCTS WITH COLON-SPECIFIC RELEASE
FI973733A0 (en) Pharmaceutical preparations and pharmaceutical preparations
ES2144077T3 (en) METHODS OF ADMINISTRATION CONTAINING SOLID SALTS OF R-TIOCTIC ACID WITH IMPROVED RELEASE AND BIOAVAILABILITY.
IS4146A (en) A pharmaceutical preparation for oral administration of proton pump blockers
DK0431877T3 (en) Cimetidine-containing pharmaceuticals
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
SE9700885D0 (en) New pharmaceutical formulation
ATE321538T1 (en) ORAL PHARMACEUTICAL FORM FOR PYRIDINE-2-YLMETHYLSULFINYL-1H-BENZIMIDAZOLE
ITTO960355A0 (en) ACTUATOR SYSTEM FOR COMPENSATION OF THE ALIGNMENT OF A MACHINE.
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
DK0742716T3 (en) Pharmaceutical composition for systemic transdermal administration with the morphine-6-glucuronide active agent
CA2057456A1 (en) Anti depression pharmaceutical
ITPN920071A0 (en) 360° ORIENTATION LOCKING SYSTEM OF THE PRE-ANGLED ABUTMENT FOR ORAL IMPLANTOLOGY.
IT1258818B (en) Oral pharmaceutical compositions based on calcium N<5>- methyltetrahydrofolate
IS4288A (en) 2,4-disulfonylphenylbutylnitron, its salts, pharmaceutical formulations together with the use of this compound in the manufacture of a medicament